The company
TG Therapeutics, Inc.
TGTX · Nasdaq
TGTX stood above a rising 150-day average in 29 of the last 52 weekly readings, including each of the last 29 weeks. It is 15.3% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 29 in a row
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $712K
- Officials’ trades on record
- 6
- Institutions holding
- 397 (+57)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 29 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
6 disclosed lines: House 1, Senate 0, executive 5; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 4 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 26 Feb 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 26 Jan 2026filed 14 May 2026 |
| Chris Jacobs House: U.S. House ClerkNY27 | sold | $1k–$15k | 8 Sep 2020filed 6 Nov 2020 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Laurence N. CharneyDirector | sold | 5,000at $54.96 | 10 Sep 2026filed 14 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 22,050,045$1.2B | -202,885−0.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026 | 7,963,266$437.5M | -310,713−3.8% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 7,786,471$427.8M | -863,295−10.0% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 6,149,403$337.8M | -453,855−6.9% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 3,642,216$200.1M | +142,300+4.1% |
| D. E. Shaw & Co., Inc.added · filed 14 Aug 2026 | 3,400,808$186.8M | +2,810,761+476.4% |
| Soleus Capital Management, L.P.reduced · filed 11 Aug 2026 | 2,927,895$160.9M | -1,101,424−27.3% |
| Clearbridge Investments, LLCreduced · filed 13 Aug 2026 | 2,650,192$145.6M | -560,738−17.5% |
| CONGRESS ASSET MANAGEMENT COadded · filed 7 Jul 2026 | 2,600,123$142.9M | +432,042+19.9% |
| TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026 | 2,468,971$135.6M | +926,659+60.1% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.